The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
7(E)-[(4-Quinoline)methylene]naltrexone ID: ALA4104363
PubChem CID: 137657770
Max Phase: Preclinical
Molecular Formula: C30H28N2O4
Molecular Weight: 480.56
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C1/C(=C/c2ccnc3ccccc23)C[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5
Standard InChI: InChI=1S/C30H28N2O4/c33-23-8-7-19-14-24-30(35)15-20(13-18-9-11-31-22-4-2-1-3-21(18)22)26(34)28-29(30,25(19)27(23)36-28)10-12-32(24)16-17-5-6-17/h1-4,7-9,11,13,17,24,28,33,35H,5-6,10,12,14-16H2/b20-13+/t24-,28+,29+,30-/m1/s1
Standard InChI Key: BVSFSOYLQNVRIS-WOXOKXDRSA-N
Molfile:
RDKit 2D
38 45 0 0 0 0 0 0 0 0999 V2000
5.2498 -20.6031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6584 -19.8974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4326 -20.6031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6460 -21.2965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0364 -21.2965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8041 -21.7876 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.2251 -19.1916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2498 -18.3744 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.0364 -19.8974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4326 -19.1916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8289 -19.8974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4756 -19.8974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4632 -21.3089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6584 -17.6522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2192 -21.2965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8289 -18.8945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4756 -17.6439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1896 -18.0401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1814 -17.2229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2192 -19.8974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8842 -20.6031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0670 -19.1792 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.8718 -22.0270 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.8065 -20.6031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7983 -22.0229 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.9391 -18.7830 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
5.6460 -22.2127 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
7.7014 -20.6085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1146 -19.9034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9400 -18.4964 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.1186 -18.4937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7091 -19.1985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3440 -19.2078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9311 -19.9074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3305 -20.6128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1427 -20.6196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5538 -19.9153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1520 -19.2128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 1 0
4 1 1 0
5 3 2 0
6 4 1 0
7 2 1 0
8 16 1 0
9 3 1 0
10 9 1 0
1 11 1 1
12 2 1 0
13 4 1 0
14 8 1 0
15 5 1 0
16 11 1 0
17 14 1 0
18 17 1 0
19 17 1 0
20 9 2 0
21 13 1 0
2 22 1 1
23 13 2 0
24 20 1 0
25 15 1 0
7 26 1 6
4 27 1 1
5 6 1 0
8 7 1 0
21 12 1 0
10 7 1 0
24 15 2 0
18 19 1 0
21 28 2 0
28 29 1 0
29 34 2 0
33 30 2 0
30 31 1 0
31 32 2 0
32 29 1 0
33 34 1 0
34 35 1 0
35 36 2 0
36 37 1 0
37 38 2 0
38 33 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 480.56Molecular Weight (Monoisotopic): 480.2049AlogP: 3.77#Rotatable Bonds: 3Polar Surface Area: 82.89Molecular Species: BASEHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.11CX Basic pKa: 8.89CX LogP: 3.57CX LogD: 2.34Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.56Np Likeness Score: 0.80
References 1. Kutsumura N, Koyama Y, Nagumo Y, Nakajima R, Miyata Y, Yamamoto N, Saitoh T, Yoshida N, Iwata S, Nagase H.. (2017) Antitrichomonal activity of δ opioid receptor antagonists, 7-benzylidenenaltrexone derivatives., 25 (16): [PMID:28662966 ] [10.1016/j.bmc.2017.06.026 ]